A review of several studies by researchers at the Cochrane Collaboration suggests that breast self-exams may be doing more harm than good among women.
A review of several studies by researchers at the Cochrane Collaboration suggests that breast self-exams may be doing more harm than good among women.
The review also included two large studies involving nearly 400,000 women in Russia and China. It found that rather than reducing breast cancer deaths, the emphasis on breast self-exams was actually increasing the number of unnecessary biopsies and scans.
Breast Cancer - Causes, Risks, Symptoms, Diagnosis, Staging, Treatment, Prevention & Prognosis
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle changes help in controlling breast cancer.
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle changes help in controlling breast cancer.
"At present, screening by breast self-examination or physical examination (by a trained health worker] cannot be recommended," said co-author Jan Peter Kosters, from the Nordic Cochrane Centre in Copenhagen. "We suggest that the lack of supporting evidence…should be discussed with these women to enable them to make an informed decision."
Source-Medindia
RAS/L
Breast Self Examination
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in women
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in women
New Light Shed On Breast Cancer Gene BRCA1
US researchers have discovered a breast cancer gene’s new role in repairing damaged DNA.
US researchers have discovered a breast cancer gene’s new role in repairing damaged DNA.
Study Confirms Benefits of Chemo, Trastuzumab Combo to Battle Breast Cancer
The meta-analysis of five major breast cancer trials has confirmed that a combination therapy of chemotherapy and antibody trastuzumab chemotherapy improves survival in women with
The meta-analysis of five major breast cancer trials has confirmed that a combination therapy of chemotherapy and antibody trastuzumab chemotherapy improves survival in women with
